Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: The ISAR-TRIPLE trial

Journal of the American College of Cardiology

Volumn 65, Issue 16, 2015, Pages 1619-1629

  Fiedler, Katrin A ^a   Maeng, Michael ^b   Mehilli, Julinda ^c,d   Schulz Schüpke, Stefanie ^a   Byrne, Robert A ^a,d   Sibbing, Dirk ^c,d   Hoppmann, Petra ^e   Schneider, Simon ^e   Fusaro, Massimiliano ^a   Ott, Ilka ^a   Kristensen, Steen D ^b   Ibrahim, Tareq ^e   Massberg, Steffen ^c,d   Schunkert, Heribert ^a,d   Laugwitz, Karl Ludwig ^d,e   Kastrati, Adnan ^a,d   Sarafoff, Nikolaus ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Deutsches Zentrum für Herz Kreislauf Forschung Partner Site   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

aspirin; atrial fibrillation; clopidogrel; percutaneous coronary intervention; vitamin K antagonist

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REBOUND; RISK ASSESSMENT; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TREATMENT DURATION; ANALOGS AND DERIVATIVES; TIME; TREATMENT OUTCOME;

AGED; ASPIRIN; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928024668     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.02.050     Document Type: Article

References (35)

1. W. Wijns, P. Kolh, and N. Danchin et al. Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
2. A. Schomig, F.J. Neumann, and A. Kastrati et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089
3. S. Connolly, J. Pogue, and R. Hart et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
4. A. Schlitt, R.S. von Bardeleben, and A. Ehrlich et al. Clopidogrel and Aspirin in the Prevention of Thromboembolic Complications After Mechanical Aortic Valve Replacement (CAPTA) Thromb Res 109 2003 131 135
5. D.P. Faxon, J.W. Eikelboom, and P.B. Berger et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective Thromb Haemost 106 2011 572 584
6. G.Y. Lip, S. Windecker, and K. Huber et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) Eur Heart J 35 2014 3155 3179
7. S. Schulz, T. Schuster, and J. Mehilli et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur Heart J 30 2009 2714 2721
8. M. Lamberts, J.B. Olesen, and M.H. Ruwald et al. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study Circulation 126 2012 1185 1193
9. J.M. Ruiz-Nodar, F. Marin, and J. Sanchez-Paya et al. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation Eur Heart J 30 2009 932 939
10. N. Sarafoff, G. Ndrepepa, and J. Mehilli et al. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation J Intern Med 264 2008 472 480
11. S. Windecker, P. Kolh, and F. Alfonso et al. 2014 ESC/EACTS Guidelines on Myocardial Revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 35 2014 2541 2619
12. C.T. January, L.S. Wann, and J.S. Alpert et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 2014 e1 e76
13. W.J. Dewilde, T. Oirbans, and F.W. Verheugt et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
14. K.A. Fiedler, R.A. Byrne, and S. Schulz et al. Rationale and design of the Intracoronary Stenting and Antithrombotic Regimen-Testing of a 6-Week Versus a 6-Month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-Eluting Stenting (ISAR-TRIPLE) study Am Heart J 167 2014 459 465.e1
15. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
16. R. Mehran, S.V. Rao, and D.L. Bhatt et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
17. K. Huber, K.J. Airaksinen, T. Cuisset, F. Marin, A. Rubboli, and G.Y. Lip Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe Thromb Haemost 106 2011 569 571
18. S. Schulz-Schüpke, R.A. Byrne, J.M. Ten Berg on behalf of the Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) trial investigators ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 versus 12 months of clopidogrel therapy after drug-eluting stenting Eur Heart J 2015 Jan 23 [E-pub ahead of print]
19. L. Mauri, D.J. Kereiakes, and R.W. Yeh et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents N Engl J Med 371 2014 2155 2166
20. S. Cassese, R.A. Byrne, T. Tada, L.A. King, and A. Kastrati Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials Eur Heart J 33 2012 3078 3087
21. F. Feres, R.A. Costa, and A. Abizaid et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial JAMA 310 2013 2510 2522
22. C.W. Lee, J.M. Ahn, and D.W. Park et al. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial Circulation 129 2014 304 312
23. S. Silber, A.J. Kirtane, and J.A. Belardi et al. Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation Eur Heart J 35 2014 1949 1956
24. G. Ndrepepa, P.B. Berger, and J. Mehilli et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697
25. G. Ndrepepa, T. Schuster, and M. Hadamitzky et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention Circulation 125 2012 1424 1431
26. G.W. Stone, B. Witzenbichler, and G. Guagliumi et al. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
27. J.M. Ruiz-Nodar, F. Marin, and J.A. Hurtado et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis J Am Coll Cardiol 51 2008 818 825
28. J.H. Alexander, R.D. Lopes, and S. James et al. Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
29. J.L. Mega, E. Braunwald, and S.D. Wiviott et al. Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
30. B.K. Kim, M.K. Hong, and D.H. Shin et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Endeavor Zotarolimus-Eluting Stent Implantation) J Am Coll Cardiol 60 2012 1340 1348
31. H.C. Gwon, J.Y. Hahn, and K.W. Park et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study Circulation 125 2012 505 513
32. A.L. Dans, S.J. Connolly, and L. Wallentin et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial Circulation 127 2013 634 640
33. N. Sarafoff, A. Martischnig, and J. Wealer et al. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation J Am Coll Cardiol 61 2013 2060 2066
34. L. Wallentin, R.C. Becker, and A. Budaj et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
35. A. Colombo, A. Chieffo, and A. Frasheri et al. Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy: the SECURITY randomized clinical trial J Am Coll Cardiol 64 2014 2086 2097